Charles Koh
Milwaukee, WINPI 1770683062
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $13,884,550 of the $13,884,646 with a category attached, or 100.0%. Coopersurgical, Inc. accounts for 98.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $3,483,596 and has fallen 75.8% since, to $843,031 in 2025.
Across 38 payments — averaging $365,385 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopersurgical, Inc.$13.7M
- KARL Storz Endoscopy-america$151K
- KARL Storz SE & Co. KG$9K
What the payments were for
- Royalty or licence$13,884,550100%
- Food & beverage$960%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopersurgical, Inc. | 31 | $13,724,286 |
| KARL Storz Endoscopy-america | 6 | $151,433 |
| KARL Storz SE & Co. KG | 1 | $8,927 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Advincula Delineator Uterine Manipulator$7,114,579
- Uterine Manipulators & Injectors$6,609,610
- CUSTOM CONTRACT CAM GYNECOLOGY$115,220
- N/A$15,356
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.